{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:47:56Z","timestamp":1776415676501,"version":"3.51.2"},"reference-count":40,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13137","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:04:13Z","timestamp":1773925453000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["Atorvastatin augments collateral formation and functional recovery after indirect revascularization in adult ischemic moyamoya disease: A randomized trial"],"prefix":"10.3892","volume":"31","author":[{"given":"Dawei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurosurgical Trauma I, Cangzhou Central Hospital, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingya","family":"Dai","sequence":"additional","affiliation":[{"name":"Administration Office, Cangzhou Central Hospital, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology Surgery III, Cangzhou Central Hospital, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Liu","sequence":"additional","affiliation":[{"name":"Anesthesia Medicine Center, Cangzhou Central Hospital, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Surgery IV, Cangzhou Central Hospital, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgical Trauma I, Cangzhou Central Hospital, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qijun","family":"Pang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgical Trauma I, Cangzhou Central Hospital, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"key20260417104534_b1-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","article-title":"Moyamoya disease: Diagnosis and interventions","volume":"21","author":"Ihara","year":"2022","journal-title":"Lancet Neurol"},{"key":"key20260417104534_b2-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1161\/STR.0000000000000443","article-title":"Adult moyamoya disease and syndrome: Current perspectives and future directions: A scientific statement from the American Heart Association\/American stroke association","volume":"54","author":"Gonzalez","year":"2023","journal-title":"Stroke"},{"key":"key20260417104534_b3-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","article-title":"Moyamoya disease emerging as an immune-related angiopathy","volume":"28","author":"Asselman","year":"2022","journal-title":"Trends Mol Med"},{"key":"key20260417104534_b4-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000448314","article-title":"Moyamoya disease","volume":"40","author":"Fujimura","year":"2016","journal-title":"Front Neurol Neurosci"},{"key":"key20260417104534_b5-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1227\/neu.0000000000002455","article-title":"The progression of pathophysiology of moyamoya disease","volume":"93","author":"Chen","year":"2023","journal-title":"Neurosurgery"},{"issue":"76","key":"key20260417104534_b6-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00318-y","article-title":"Moyamoya disease: Epidemiology, clinical features, pathogenesis, diagnosis and therapeutic interventions","volume":"6","author":"Cheng","year":"2025","journal-title":"Mol Biomed"},{"key":"key20260417104534_b7-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1007\/s12350-022-03148-5","article-title":"Coronary vasculopathy due to moyamoya disease","volume":"30","author":"Kaur","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"e70054","key":"key20260417104534_b8-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70054","article-title":"Advances in moyamoya disease: Pathogenesis, diagnosis, and therapeutic interventions","volume":"6","author":"He","year":"2025","journal-title":"MedComm (2020)"},{"key":"key20260417104534_b9-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s10143-018-0994-5","article-title":"Progress in moyamoya disease","volume":"43","author":"Shang","year":"2020","journal-title":"Neurosurg Rev"},{"key":"key20260417104534_b10-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s10143-020-01393-1","article-title":"Limits and pitfalls of indirect revascularization in moyamoya disease and syndrome","volume":"44","author":"Fiaschi","year":"2021","journal-title":"Neurosurg Rev"},{"issue":"1115909","key":"key20260417104534_b11-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1115909","article-title":"Natural course and risk factors of moyamoya disease with unruptured intracranial aneurysm","volume":"14","author":"Yang","year":"2023","journal-title":"Front Neurol"},{"key":"key20260417104534_b12-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3171\/2023.7.JNS231060","article-title":"Long-term outcomes after conservative and EDAS treatment for 111 elderly patients with moyamoya disease: Longitudinal and cross-sectional study","volume":"140","author":"Li","year":"2023","journal-title":"J Neurosurg"},{"key":"key20260417104534_b13-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jbiomech.2014.11.029","article-title":"Identification of a hemodynamic parameter for assessing treatment outcome of EDAS in Moyamoya disease","volume":"48","author":"Karunanithi","year":"2015","journal-title":"J Biomech"},{"issue":"861187","key":"key20260417104534_b14-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.861187","article-title":"Recognition of the effect of indirect revascularization for moyamoya disease: The balance between the stage progression and neoangiogenesis","volume":"13","author":"Bao","year":"2022","journal-title":"Front Neurol"},{"key":"key20260417104534_b15-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.nec.2017.02.004","article-title":"Direct versus indirect bypass for moyamoya disease","volume":"28","author":"Liu","year":"2017","journal-title":"Neurosurg Clin N Am"},{"issue":"E14","key":"key20260417104534_b16-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.3171\/2018.11.FOCUS18517","article-title":"Effect of revascularization on cognitive outcomes in intracranial steno-occlusive disease: A systematic review","volume":"46","author":"Kolb","year":"2019","journal-title":"Neurosurg Focus"},{"key":"key20260417104534_b17-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.47391\/JPMA.4823","article-title":"Comparison of efficiency between Rosuvastatin and Atorvastatin in reducing low-density lipoprotein (LDL-C) in patients with diabetes mellitus","volume":"72","author":"Khokhar","year":"2022","journal-title":"J Pak Med Assoc"},{"issue":"e174125","key":"key20260417104534_b18-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174125","article-title":"High-dose atorvastatin therapy progressively decreases skeletal muscle mitochondrial respiratory capacity in humans","volume":"9","author":"Ryan","year":"2024","journal-title":"JCI Insight"},{"issue":"e70138","key":"key20260417104534_b19-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.1002\/clc.70138","article-title":"Lipid-lowering effect and safety of ezetimibe and atorvastatin 5 mg in patients with primary hypercholesterolemia or mixed dyslipidemia: A randomized, double-blind, parallel, multicenter, phase 3 clinical trial","volume":"48","author":"Ki","year":"2025","journal-title":"Clin Cardiol"},{"key":"key20260417104534_b20-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5414\/CP204025","article-title":"Dose-dependent atorvastatin associated with angioedema","volume":"60","author":"Al-Qaaneh","year":"2022","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key20260417104534_b21-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/RNN-201012","article-title":"Prestroke statin use enhances collateralization in acute ischemic stroke patients","volume":"38","author":"Zhu","year":"2020","journal-title":"Restor Neurol Neurosci"},{"key":"key20260417104534_b22-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2174\/138161207781039724","article-title":"Regulation of angiogenesis and angiogenic factors by cardiovascular medications","volume":"13","author":"Miura","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"107518","key":"key20260417104534_b23-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2025.107518","article-title":"Effects of simvastatin treatment on leptomeningeal collateral vessels: Resistance, number and diameter","volume":"160","author":"Williams","year":"2025","journal-title":"Vascul Pharmacol"},{"key":"key20260417104534_b24-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: Current concepts and future perspectives","volume":"7","author":"Kuroda","year":"2008","journal-title":"Lancet Neurol"},{"key":"key20260417104534_b25-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-3-031-89844-0_11","article-title":"Long-Term outcome of moyamoya disease","volume":"136","author":"Birkeland","year":"2025","journal-title":"Acta Neurochir Suppl"},{"issue":"e3","key":"key20260417104534_b26-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2023-002998","article-title":"Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: Executive summary and 2023 update","volume":"6","author":"Liu","year":"2023","journal-title":"Stroke Vasc Neurol"},{"issue":"E9","key":"key20260417104534_b27-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.3171\/2021.6.FOCUS21112","article-title":"The role of atorvastatin in collateral circulation formation induced by encephaloduroarteriosynangiosis: A prospective trial","volume":"51","author":"Wang","year":"2021","journal-title":"Neurosurg Focus"},{"key":"key20260417104534_b28-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.3171\/2023.10.JNS231660","article-title":"A novel system for evaluating collateralization of the external carotid artery after cerebral revascularization in moyamoya disease","volume":"140","author":"Li","year":"2023","journal-title":"J Neurosurg"},{"key":"key20260417104534_b29-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/23969873221144089","article-title":"European stroke organisation (ESO) guidelines on moyamoya angiopathy endorsed by vascular european reference network (VASCERN)","volume":"1","author":"Bersano","year":"2023","journal-title":"Eur Stroke J"},{"key":"key20260417104534_b30-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/j.wneu.2018.10.001","article-title":"Progressive shrinkage of involved arteries in parallel with disease progression in moyamoya disease","volume":"122","author":"Yamamoto","year":"2019","journal-title":"World Neurosurg"},{"key":"key20260417104534_b31-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.niox.2022.01.001","article-title":"An updated systematic review and meta-analysis of the effect of statins on asymmetric dimethylarginine","volume":"120","author":"Zinellu","year":"2022","journal-title":"Nitric Oxide"},{"issue":"e0332","key":"key20260417104534_b32-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000332","article-title":"Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial","volume":"7","author":"Kronborg","year":"2023","journal-title":"Hepatol Commun"},{"issue":"1169253","key":"key20260417104534_b33-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1169253","article-title":"To explore the effectiveness of atorvastatin in the postoperative formation of collateral blood vessels after encephaloduroarteriosynangiosis in patients with moyamoya disease: A prospective double-blind randomized controlled study","volume":"14","author":"Gao","year":"2023","journal-title":"Front Neurol"},{"key":"key20260417104534_b34-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.7326\/M24-0178","article-title":"comparative effectiveness and safety of atorvastatin versus rosuvastatin : A multi-database cohort study","volume":"12","author":"Zhou","year":"2024","journal-title":"Ann Intern Med"},{"issue":"103381","key":"key20260417104534_b35-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103381","article-title":"Comparative effectiveness and safety of atorvastatin versus rosuvastatin among patients with ischemic stroke or transient ischemic attack: A national registry-based observational study","volume":"86","author":"Zhao","year":"2025","journal-title":"EClinicalMedicine"},{"key":"key20260417104534_b36-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1021\/acs.biochem.7b01012","article-title":"Drug-Drug interactions between atorvastatin and dronedarone mediated by monomeric CYP3A4","volume":"5","author":"Denisov","year":"2018","journal-title":"Biochemistry"},{"key":"key20260417104534_b37-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biopha.2009.03.003","article-title":"Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1","volume":"64","author":"Ara\u00fajo","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"key20260417104534_b38-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41551-021-00764-3","article-title":"Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells","volume":"5","author":"Tian","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"key20260417104534_b39-ETM-31-5-13137","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1474-4422(25)00036-5","article-title":"Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): A phase 1\/2a, randomised placebo-controlled trial","volume":"24","author":"Awad","year":"2025","journal-title":"Lancet Neurol"},{"issue":"118275","key":"key20260417104534_b40-ETM-31-5-13137","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118275","article-title":"Cilostazol attenuates vascular inflammation via the regulation of TICAM1\/IRF3 signaling pathway","volume":"189","author":"Chiu","year":"2025","journal-title":"Biomed Pharmacother"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:46:37Z","timestamp":1776411997000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,19]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13137","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}